2020 IDWeek*

October 21-25, 2020; Virtual Conference
Get the latest data on HIV management with expert commentaries covering key studies from this important annual conference.
Eric S. Daar, MD
Babafemi Taiwo, MBBS

HIV Highlights

Join me on a review of 5 impactful studies on the use of long-acting cabotegravir plus rilpivirine presented at the IDWeek 2020 virtual conference and how I believe these data will impact clinical practice.

Babafemi Taiwo, MBBS Released: November 23, 2020

Learn about new data presented at the IDWeek 2020 virtual conference on the use of bictegravir/emtricitabine/tenofovir alafenamide in individuals with HIV and end-stage renal disease on hemodialysis.

Eric S. Daar, MD Released: December 11, 2020
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Educational grant provided by:
Janssen Therapeutics, Division of Janssen Products, LP

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue